Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing atherosclerotic cardiovascular disease

Prevention is an essential component of any effort to improve population health and ultimately reduce spending. While some prevention efforts are cost-saving, some strategies that improve health will increase total spending. Nonetheless, millions of people in the US taking statins do not achieve LDL-C goals, indicating a significant clinical burden among those with, or at risk for, ASCVD, resulting in substantial healthcare resource use and costs.